Category Archives: Uncategorized

The Plasticisers Industry Calls for Regulatory Predictability to Enable Protection of Consumer Health as well as Competitiveness and Growth

May 3, 2016. Europe. “The European Council for plasticisers and Intermediates (ECPI) is pleased to learn that the REACH Committee has confirmed the Authorisation of the recycling of…”

OXSOFT L9TM replacing C8C10 trimellitates

Stable availability and performance are key requirement for plasticizers used in automotive applications. Globally there is plenty of plasticizer capacity available. However some key raw materials do have structural limitations. Linear alcohols in general and linear alcohols of chain length 8 and 10 in specific do have availability constraints. Both the natural as well as […]

Plastics and medical devices – technical properties in a historical perspective

Content contributed by Tobias Johnsen, MA, writer of PVC Med Alliance. Imagine a world without plastics. The computer on your desktop, the TV on your wall and the credit card in your wallet would not exist. The car you drive would weigh more and have worse mileage, and though your smartphone may have an exterior made […]

Jury still out on DEHP and medical devices

April 13, 2015. Europe. DEHP is one of the several plasticisers used in PVC medical devices. Scientists agree that DEHP can leach into the body from tubes, blood bags and other essential …

Oxea receives European Product Leadership Award for its Phthalate-free Plasticizer product range

March 19, 2015. Oberhausen, Germany. Based on its recent analysis of the European plasticizers market, Growth Partnership Firm Frost & Sullivan has recognized chemical company Oxea with the ‘2014 European Non-Phthalate Plasticizers Product Leadership Award’. The researchers …

REACH restrictions updated for PAHs and phthalates

4 March 2015. Europe, Priority substances. An EU Regulation amending the REACH restrictions for polycyclic aromatic hydrocarbons (PAHs) and phthalates was published in the EU Official Journal on 3 March. CW 28 May 2014 CW 5 February 2014

DEHP and its endocrine effects

February 2015. Europe. Global Business Briefing. On 17 December 2014, Echa amended the entry for Bis (2-ethylhexyl)phthalate (DEHP) on the candidate list of substances of very high concern (SVHCs) to indicate that the substance meets the Article 57(f) criterion of equivalent level … CW 16 December 2014 CW 19 December 2014

ECHA defends its views on DEHP authorisation

28 January 2015. Europe. ECHA has rejected claims by a group of NGOs that there are “procedural and substantive flaws” in the draft opinions, adopted by its Committees on Risk Assessment (RAC) and Socio-Economic Analysis (SEAC), which concluded …

California proposes no significant risk level for DINP

23 December 2014, United States. California is starting a rulemaking to adopt a no significant risk level (NSRL) for diisononyl phthalate (DINP) under Proposition 65. The Office of Environmental Health Hazard Assessment (OEHHA) is proposing …

Continuous battle against DEHP drives demand for alternative plasticizers for PVC in medical

Early this month, Denmark proposed four phthalates to be identified as substances of very high concern (SVHCs) for their endocrine disrupting properties for human health and the environment. Member State Committee subsequently agreed that the endocrine disrupting properties of DEHP indeed cause concern for the environment. With the series of activities that Denmark has embarked […]

PVC & Plasticizers: What, Where & Why